Nevro (NYSE: NVRO) is a public multinational medical technology company headquartered in Redwood City, California. We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform.
We started with a simple mission to help more patients suffering from chronic pain. At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has impacted the lives of over 28,000 patients around the world.
The Nevro® Senza® SCS System received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States.
Openings for continuing students (undergraduate and graduate) and to apply their engineering expertise in research and development activities. The student interns will conduct research and do development in the following areas: electrical engineering, integrated circuit design, wireless communication, wireless charging, electrochemistry, bioengineering, biochemistry, biomaterials, biosensors, micropackaging, neuroengineering, neurophysiology, neurobiology, signal processing, computational modeling, and materials.